May ecommerce sales jumped 132% and the matcha platform just shifted from launch into commercial fulfilment.
OMG Group (ASX:OMG) just delivered a Q4 trading update that quietly shifts the shape of the investment story. Net sales on a moving annual total basis reached roughly A$6.2 million to May 2026, up about 57% on the prior year. That keeps the company on a steady upward step, building on the A$6.0 million MAT milestone reported at the end of Q3 FY26.
But the headline number is not the most interesting thing in this release. May 2026 net sales of around A$650,000 were up roughly 75% on the prior corresponding period, marking one of the strongest trading months in OMG’s history. Within that, ecommerce sales of about A$287,000 were up roughly 132%, materially outpacing the rest of the business.
The other piece worth flagging is the matcha platform. OMG’s first commercial shipment of ceremonial-grade Japanese matcha under its five-year SANDAI Group supply agreement has now landed in Australia. That moves the matcha story out of the launch and airfreight phase and into something closer to a real distribution business.
Ecommerce is now compounding faster than the rest of the business
Ecommerce MAT sales of A$2.4 million now represent roughly 39% of total MAT revenue, up from a much smaller slice the year prior. The channel grew about 87% on a MAT basis while the wider business grew 57%. That gap matters because direct ecommerce typically carries fatter margins than grocery or convenience channels.
Within May itself, the ecommerce mix tilts even harder. A 132% jump in monthly ecommerce sales versus 75% growth in total net sales tells you the digital channel is accelerating, not just keeping pace. Repeat purchase behaviour and brand recognition appear to be doing the heavy lifting here.
We think this is the line item investors should be anchoring on for FY27. If ecommerce continues to compound at this rate, the gross margin profile of the business changes meaningfully, which is what eventually re-rates a consumer brand of this size.
Chemist Warehouse New Zealand is a footprint trade, not a revenue trade
Blue Dinosaur securing a national ranging agreement with Chemist Warehouse New Zealand via ANZ Pharma adds a new retail channel across roughly 88 stores. Chemist Warehouse is one of Australasia’s largest pharmacy retail chains, with more than 570 stores across Australia and a meaningful presence in New Zealand. For Blue Dinosaur, this is the first material international pharmacy retail listing.
Worth noting though, national ranging is not the same as guaranteed sell-through. Ranging gets the product on the shelf. Whether it stays there depends on velocity, marketing spend and how shoppers actually respond, none of which we will see clean data on for at least one or two quarters.
The strategic value is the distribution footprint and the validation effect on other pharmacy and FMCG buyers across the region. Treat the announcement as setup, not yet a revenue catalyst.
The matcha platform has just shifted from story to supply chain
Until this quarter, OMG’s matcha business was effectively a thesis with some airfreight samples attached. The arrival of the first commercial sea-freight shipment of ceremonial-grade matcha under the SANDAI supply agreement changes the picture. The company can now fulfil ingredient supply orders to wholesale and food service customers at scale, including through Food & Dairy Co and The Little Marionette.
Independent validation is also starting to appear. House of Matcha, a Byron Bay wellness beverage brand using OMG-supplied matcha, won the Launch Legend Award at the 2026 BiteBack Awards. That is a real signal that the underlying product quality stands up in front of food service buyers.
The Omura Matcha exhibition at the inaugural Cafe & Coffee Show in Sydney is the channel building piece of the same puzzle. Whether those buyer conversations turn into ranging decisions across cafe chains is the next test.
The Investors Takeaway for OMG Group
OMG is heading into FY27 with three things working in its favour. A 57% growth rate on a A$6.2 million revenue base, an ecommerce channel compounding well above the group average, and a matcha platform that has just moved from launch into commercial fulfilment. That is a more interesting setup than the headline MAT number alone suggests.
The honest question for investors is whether the Chemist Warehouse New Zealand listing and the SANDAI shipment translate into a visible revenue contribution by the Q1 FY27 update, or whether they remain footprint stories for another two quarters. We would want to see matcha called out as a separate revenue line and ecommerce continuing to track above 80% growth before assigning much premium to the multiple. Investors can find more in-depth coverage of small-cap consumer and wellness names at stocksdownunder.
